NCT07449273 Breathing Interventions for Postoperative Breast Surgery Patients
| NCT ID | NCT07449273 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ondokuz Mayıs University |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 126 participants |
| Start Date | 2026-05-13 |
| Primary Completion | 2027-02-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 126 participants in total. It began in 2026-05-13 with a primary completion date of 2027-02-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effects of pranayama and pursed-lip breathing exercises on postoperative pain, anxiety, and vital signs in patients undergoing breast surgery. Postoperative pain and anxiety are common problems that can negatively affect recovery, physiological stability, and overall well-being. Non-pharmacological interventions such as breathing exercises may help reduce these adverse outcomes and support recovery. Participants will be randomly assigned to one of three groups: a pranayama breathing exercise group, a pursed-lip breathing exercise group, or a control group receiving routine postoperative care. Breathing exercises will be performed three times daily for five minutes. Outcomes including pain, anxiety, and vital signs will be measured at baseline (pretest), postoperative day 1, and postoperative day 2. The findings of this study are expected to provide evidence on the effectiveness of breathing exercises as supportive nursing interventions in the postoperative care of breast surgery patients.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and older * Able to communicate effectively * Patients undergoing elective surgery for the first time, including radical mastectomy, modified radical mastectomy, or simple mastectomy Exclusion Criteria: * Patients undergoing breast-conserving surgery * Patients who develop any postoperative complications, such as bleeding or anesthesia-related complications * Individuals with cognitive or mental impairments * Patients who wish to withdraw from the study at any stage * Patients with hearing or speech impairments * Patients with a psychiatric diagnosis or those using psychiatric medications * Patients unable to comply with breathing exercises
Contact & Investigator
Özge İşeri, Assistant Professor
PRINCIPAL INVESTIGATOR
Ondokuz Mayıs University, Faculty of Health Sciences, Department of Nursing, Samsun, Türkiye
Frequently Asked Questions
Who can join the NCT07449273 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07449273 currently recruiting?
Yes, NCT07449273 is actively recruiting participants. Contact the research team at akbasgonca0@gmail.com for enrollment information.
Where is the NCT07449273 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07449273 clinical trial?
NCT07449273 is sponsored by Ondokuz Mayıs University. The principal investigator is Özge İşeri, Assistant Professor at Ondokuz Mayıs University, Faculty of Health Sciences, Department of Nursing, Samsun, Türkiye. The trial plans to enroll 126 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.